G A Calin

Author PubWeight™ 30.91‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 2008 4.11
2 miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ 2009 3.94
3 Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene 2012 3.83
4 Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 2007 3.29
5 MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 2007 2.79
6 A microRNA component of the hypoxic response. Cell Death Differ 2008 2.59
7 miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ 2009 1.82
8 CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene 2010 1.65
9 MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications. Leukemia 2008 1.53
10 Targeting microRNAs with small molecules: from dream to reality. Clin Pharmacol Ther 2010 1.04
11 The role of microRNA in human leukemia: a review. Leukemia 2009 1.03
12 Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas. Proc Natl Acad Sci U S A 2000 0.99
13 HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts. Cell Death Differ 2013 0.94
14 Abnormal RNA expression of 11p15 imprinted genes and kidney developmental genes in Wilms' tumor. Cancer Res 2000 0.89
15 Chronic lymphocytic leukemia: molecular genetics and animal models. Curr Top Microbiol Immunol 2005 0.87
16 Cloning and characterization of cDNAs expressed during chick development and encoding different isoforms of a putative zinc finger transcriptional regulator. Biochimie 2005 0.78
17 Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 2016 0.75